Prognostic significance of antrum-predominant gastritis in functional dyspepsia

Scandinavian Journal of Gastroenterology

Volumn 39, Issue 3, 2004, Pages 227-231

  Heikkinen, M ^a   Vornanen, M ^b   Hollmen S ^b   Farkkila M ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b NONE

Author keywords

Follow up; Functional dyspepsia; Gastritis; General practice; Helicobacter pylori; Prognosis; Topography

Indexed keywords

ADULT; COLONOSCOPY; CONTROLLED STUDY; DYSPEPSIA; ENDOSCOPY; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTRITIS; GASTROSCOPY; GENERAL PRACTICE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIGMOIDOSCOPY; STOMACH ANTRUM;

CASE-CONTROL STUDIES; DYSPEPSIA; FEMALE; FOLLOW-UP STUDIES; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PYLORIC ANTRUM; TIME FACTORS;

EID: 1642299560     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520310008287     Document Type: Review

References (37)

1. Warndorff DK, Knottnerus JA, Huijnen LGL, Starmans R. How well do general practitioners manage dyspepsia? J R Coll Gen Pract 1989;39:499-502.
2. Heikkinen M, Pikkarainen P, Takala J, Julkunen R. General practitioners' approach to dyspepsia. Survey of consultation frequencies, treatment, and investigations. Scand J Gastroenterol 1996;31:648-53.
3. Kagevi I, Löfstedt S, Persson L-G. Endoscopic findings and diagnoses in unselected dyspeptic patients at a primary health care center. Scand J Gastroenterol 1989;24:145-50.
4. Klauser AG, Voderholzer WA, Knesewitsch PA, Schindlbeck NE, Müller-Lissner SA. What is behind dyspepsia? Dig Dis Sci 1993;38:147-54.
5. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;1:1273-5.
6. Rauws EAJ, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GNJ. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988;94: 33-40.
7. Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI, et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 1989;321:1562-6.
8. Bernersen B, Johnsen R, Bostad L, Straume B, Sommer A-I, Burhol PG. Is Helicobacter pylori the cause of dyspepsia? Br Med J 1992;304:1276-9.
9. Valle J, Kekki M, Sipponen P, Ihamäki T, Siurala M. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol 1996;31: 546-50.
10. Sipponen P, Kekki M, Seppälä K, Siurala M. The relationship between chronic gastritis and gastric acid secretion. Aliment Pharmacol Ther 1996;10 Suppl 1:103-8.
11. El-Omar EM, Oen K, El-Nujumi A, Gillen D, Wirz A, Dahill S, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997;113:15-24.
12. Malfertheiner P, Megraud F, O'Morain CO, Hungin APS, Jones R, Axon A, et al. Current concepts in the management of Helicobacter pylori infection: The Maastricht 2-2000 consensus report. Aliment Pharmacol Ther 2002;16:167-80.
13. McColl K, Murray L, El-Omar E, Dickson A, El-Nujumi A, Wirz A, et al. Symptomatic benefit from eradicating Helicobacter pylori infection in nonulcer dyspepsia. N Engl J Med 1998;339: 1869-74.
14. Blum AL, Talley NJ, O'Morain C, Veldhuyzen van Zanten S, Labenz J, Stolte M, et al. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998;339:1875-81.
15. Talley NJ, Vakil N, Ballard II ED, Fennerty B. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med 1999;341:1106-11.
16. Moayyedi P, Soo S, Deeks J, Forman D, Mason J, Innes M, et al. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Br Med J 2000;321:659-64.
17. Danesh J, Lawrence M, Murphy M, Roberts S, Collins R. Systematic review of the epidemiological evidence on Helicobacter pylori infection and nonulcer or uninvestigated dyspepsia. Arch Intern Med 2000;160:1192-8.
18. Talley NJ, Janssens J, Lauritsen K, Rácz I, Bolling-Sternevald E. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. Br Med J 1999;318:833-7.
19. Koskenpato J, Färkkilä M, Sipponen P. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia. Scand J Gastroenterol 2002;37:778-84.
20. Heikkinen M, Pikkarainen P, Takala J, Räsänen H, Julkunen R. Etiology of dyspepsia: four hundred unselected consecutive patients in general practice. Scand J Gastroenterol 1995;30:519-23.
21. Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyrén O, Stanghellini V. Functional dyspepsia: a classification with guidelines for diagnosis and management. Working Team report. Gastroenterol Int 1991;4:145-60.
22. Feldman RA, Deeks JJ. Evans SJW and the Helicobacter pylori Serology Study Group. Multi-laboratory comparison of eight commercially available Helicobacter pylori serology kits. Eur J Clin Microbiol Infect Dis 1995;14:428-33.
23. Price AB. The Sydney system: histological division. J Gastroenterol Hepatol 1991;6:209-22.
24. Sipponen P, Seppälä K, Äärynen M, Helske T, Kettunen P. Chronic gastritis and gastroduodenal ulcer: a case control study on risk of coexisting duodenal or gastric ulcer in patients with gastritis. Gut 1989;30:922-9.
25. Sipponen P, Varis K, Fräki O, Korri U-M, Seppälä K, Siurala M. Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. A clinical follow-up study of 454 outpatients. Scand J Gastroenterol 1990; 25:966-73.
26. El-Zimaity HMT, Gutierrez O, Kim JG, Akamatsu T, Gurer IE, Simjee AE, et al. Geographic differences in the distribution of intestinal metaplasia in duodenal ulcer patients. Am J Gastroenterol 2002;96:196-202.
27. Olbe L, Hamlet A, Dalenbäck J, Fändrinks L. A mechanism by which Helicobacter pylori infection of the antrum contributes to the development of duodenal ulcer. Gastroenterology 1996;110: 1386-94.
28. O'Connor HJ, O'Morain CA. Helicobacter pylori and gastroesophageal reflux disease: to treat or not to treat? Review. Scand J Gastroenterol 2001;7:677-82.
29. Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO). Prevalence of gallstone disease in an Italian adult female population. Am J Epidemiol 1984;19:796-805.
30. Barbara L, Sama L, Morselli Labate AM, Taroni F, Rusticali AG, et al. A population study on the prevalence of gallstone disease: the Sirmione study. Hepatology 1987;7:913-7.
31. Bates T, Ebbs R, Harrison M, A'Hern RP. Influence of cholecystectomy on symptoms. Br J Surg 1991;78:964-7.
32. Rekola KE, Keinänen-Kiukaanniemi S, Takala J. Use of primary health services in sparsely populated country districts by patients with musculoskeletal symptoms: consultations with a physician. J Epidemiol Community Health 1993;47:153-7.
33. Sloth H, Jørgensen LS. Chronic non-organic upper abdominal pain: diagnostic safety and prognosis of gastrointestinal and non-intestinal symptoms. A 5- to 7-year follow-up study. Scand J Gastroenterol 1988;23:1275-80.
34. Barnes RJ, Uff JS, Dent JC, Gear MW, Wilkinson SP. Long-term follow up of patients with gastritis associated with Helicobacter pylori infection. Br J Gen Pract 1991;41:286-8.
35. Lindell GH, Celebioglu F, Graffer HO. Non-ulcer dyspepsia in the long-term perspective. Eur J Gastroenterol Hepatol 1995;7: 829-33.
36. Meineche-Schmidt V, Jørgensen T. Investigation and therapy in patients with different types of dyspepsia: a 3-year follow-up study from general practice. Fam Pract 2000;17:514-21.
37. Hsu P-I, Lai K-H, Lo G-H, Tseng HH, Lo CC, Chen HC, et al. Risk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two-year follow-up study of 209 patients. Gut 2002;51:15-20.